An epidemic CC1-MRSA-IV clone yields false-negative test results in molecular MRSA identification assays: a note of caution, Austria, Germany, Ireland, 2020

Euro Surveill. 2020 Jun;25(25):2000929. doi: 10.2807/1560-7917.ES.2020.25.25.2000929.

Abstract

We investigated why a clinical meticillin-resistant Staphylococcus aureus (MRSA) isolate yielded false-negative results with some commercial PCR tests for MRSA detection. We found that an epidemic European CC1-MRSA-IV clone generally exhibits this behaviour. The failure of the assays was attributable to a large insertion in the orfX/SCCmec integration site. To ensure the reliability of molecular MRSA tests, it is vital to monitor emergence of new SCCmec types and junction sites.

Keywords: BD MAX, next generation sequencing; CC1-MRSA-IV; Cepheid GenXpert; Staphylococci; Staphylococcus aureus; commercial PCR.

Publication types

  • Case Reports

MeSH terms

  • Austria / epidemiology
  • False Negative Reactions
  • Female
  • Germany / epidemiology
  • Humans
  • Ireland / epidemiology
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Middle Aged
  • Staphylococcal Infections / diagnosis*
  • Staphylococcal Infections / epidemiology